Page last updated: 2024-08-24

edda and tricine

edda has been researched along with tricine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
He, J; Hnatowich, DJ; Rusckowski, M; Su, ZF1
Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E1
Bai, Y; Chang, Y; Chen, S; Li, Z; Teng, B1
Avcı, CB; Durkan, K; Gündüz, C; Ozgür, A; Susluer, SY; Yurt Lambrecht, F1
Erfani, M; Mohammadbaghery, F; Shamsaei, M; Shirmardi, SP1
Cabral, P; Fernandez, M; Gallazzi, F; Gambini, JP; Garcia, MF; Moreno, M; Porcal, W; Quinn, TP; Zhang, X1
Cheng, D; Li, B; Lin, QY; Meng, L; Shi, H; Tan, H; Zhang, Y1
Geramifar, P; Mazidi, SM; Mosayebnia, M; Nami, R; Rezaeianpour, M1

Other Studies

8 other study(ies) available for edda and tricine

ArticleYear
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
    Nuclear medicine and biology, 2003, Volume: 30, Issue:2

    Topics: Blood Proteins; Cells, Cultured; Edetic Acid; Endothelium, Vascular; Glycine; Humans; Hydrazines; Integrins; Ligands; Metabolic Clearance Rate; Nicotinic Acids; Oligopeptides; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Umbilical Veins

2003
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:8

    Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution

2007
Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
    Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12

    Topics: Chelating Agents; Edetic Acid; Glycine; Isotope Labeling; Ligands; Magnetic Resonance Imaging; Models, Chemical; Neoplasms; Radiopharmaceuticals; Technetium; Thymidine

2007
In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Journal of drug targeting, 2013, Volume: 21, Issue:4

    Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Edetic Acid; Glycine; Humans; Hydrazines; Ligands; Mice; Niacinamide; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Receptors, Bombesin

2013
Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging.
    Journal of labelled compounds & radiopharmaceuticals, 2014, May-30, Volume: 57, Issue:6

    Topics: Animals; Biological Transport; Chemistry Techniques, Synthetic; Edetic Acid; Glycine; Humans; Mammary Neoplasms, Experimental; Mice; Molecular Imaging; Organotechnetium Compounds; Tissue Distribution; Tubulin

2014
Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Anti-cancer agents in medicinal chemistry, 2015, Volume: 15, Issue:1

    Topics: alpha-MSH; Animals; Chelating Agents; Diagnostic Imaging; Edetic Acid; Glycine; Hydrazines; Ligands; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nicotinic Acids; Organotechnetium Compounds; Peptides; Protein Binding; Radiopharmaceuticals; Tissue Distribution

2015
Preliminary application of micro-SPECT/CT imaging by
    Chemical biology & drug design, 2019, Volume: 93, Issue:4

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Edetic Acid; Glycine; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Mice, Nude; Nicotinic Acids; Organotechnetium Compounds; Proto-Oncogene Proteins c-met; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous

2019
Vimentin-targeted radiopeptide 99m Tc-HYNIC-(tricine/EDDA)-VNTANST: a promising drug for pulmonary fibrosis imaging.
    Nuclear medicine communications, 2023, Sep-01, Volume: 44, Issue:9

    Topics: Animals; Cell Line, Tumor; Humans; Intermediate Filaments; Mice; Organotechnetium Compounds; Pulmonary Fibrosis; Radiopharmaceuticals; Technetium; Tissue Distribution; Vimentin

2023